Mark S. Stein

1.8k total citations
22 papers, 1.4k citations indexed

About

Mark S. Stein is a scholar working on Pathology and Forensic Medicine, Orthopedics and Sports Medicine and Surgery. According to data from OpenAlex, Mark S. Stein has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 9 papers in Orthopedics and Sports Medicine and 5 papers in Surgery. Recurrent topics in Mark S. Stein's work include Vitamin D Research Studies (11 papers), Bone health and osteoporosis research (7 papers) and Parathyroid Disorders and Treatments (5 papers). Mark S. Stein is often cited by papers focused on Vitamin D Research Studies (11 papers), Bone health and osteoporosis research (7 papers) and Parathyroid Disorders and Treatments (5 papers). Mark S. Stein collaborates with scholars based in Australia, United Kingdom and China. Mark S. Stein's co-authors include John D. Wark, Leon Flicker, Samuel Scherer, Leonard C. Harrison, Robert J. MacInnis, Caryl Nowson, Sam Scherer, John L. Hopper, Peter R. Ebeling and S A Feik and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Diabetes Care.

In The Last Decade

Mark S. Stein

22 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark S. Stein Australia 14 732 491 238 229 213 22 1.4k
Beatriz Oliveri Argentina 21 534 0.7× 513 1.0× 239 1.0× 195 0.9× 173 0.8× 64 1.3k
Frazer H. Anderson United Kingdom 13 936 1.3× 1000 2.0× 285 1.2× 448 2.0× 268 1.3× 18 2.0k
Mary K. Beard United States 7 994 1.4× 472 1.0× 274 1.2× 363 1.6× 86 0.4× 12 1.4k
Göran Toss Sweden 24 303 0.4× 787 1.6× 271 1.1× 174 0.8× 649 3.0× 48 2.1k
C. L. Donaldson United States 7 533 0.7× 731 1.5× 263 1.1× 236 1.0× 215 1.0× 12 1.3k
Lisa Ceglia United States 20 969 1.3× 331 0.7× 814 3.4× 286 1.2× 127 0.6× 47 1.8k
P Bordier France 22 481 0.7× 445 0.9× 412 1.7× 177 0.8× 214 1.0× 87 2.0k
Edith Lau Hong Kong 19 288 0.4× 447 0.9× 310 1.3× 111 0.5× 226 1.1× 33 1.3k
Anna Maria Formenti Italy 25 616 0.8× 230 0.5× 152 0.6× 347 1.5× 323 1.5× 52 1.8k
Kerry E Broe United States 25 443 0.6× 1.1k 2.3× 491 2.1× 440 1.9× 535 2.5× 33 2.3k

Countries citing papers authored by Mark S. Stein

Since Specialization
Citations

This map shows the geographic impact of Mark S. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Stein more than expected).

Fields of papers citing papers by Mark S. Stein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Stein. The network helps show where Mark S. Stein may publish in the future.

Co-authorship network of co-authors of Mark S. Stein

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Stein. A scholar is included among the top collaborators of Mark S. Stein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Stein. Mark S. Stein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stein, Mark S., Victor Kalff, Scott Williams, et al.. (2023). The GLP-1 receptor is expressed in vivo by human metastatic prostate cancer. SHILAP Revista de lepidopterología. 4(1). e230015–e230015. 7 indexed citations
2.
Stein, Mark S., Gregory J. Ward, Helmut Butzkueven, Trevor J. Kilpatrick, & Leonard C. Harrison. (2018). Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study. Molecular Medicine. 24(1). 27–27. 6 indexed citations
3.
Mitchell, Peter, Trevor J. Kilpatrick, Mark S. Stein, et al.. (2012). Diffusion tensor imaging of acute inflammatory lesion evolution in multiple sclerosis. Journal of Clinical Neuroscience. 19(12). 1689–1694. 13 indexed citations
4.
Stein, Mark S., et al.. (2011). A Randomized Controlled Trial of High-Dose Vitamin D2 Followed by Intranasal Insulin in Alzheimer's Disease. Journal of Alzheimer s Disease. 26(3). 477–484. 128 indexed citations
5.
Stein, Mark S., Orla Gray, Josephine Baker, et al.. (2011). A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology. 77(17). 1611–1618. 136 indexed citations
6.
Stein, Mark S.. (2007). Vitamin D deficiency. -letter-. 36(9). 680. 1 indexed citations
7.
Fourlanos, Spiros, Christine Perry, Mark S. Stein, et al.. (2006). A Clinical Screening Tool Identifies Autoimmune Diabetes in Adults. Diabetes Care. 29(5). 970–975. 89 indexed citations
8.
Flicker, Leon, Robert J. MacInnis, Mark S. Stein, et al.. (2006). RESPONSE LETTER TO DR. GAU ET AL.. Journal of the American Geriatrics Society. 54(6). 1021–1022. 2 indexed citations
9.
Flicker, Leon, Robert J. MacInnis, Mark S. Stein, et al.. (2005). Should Older People in Residential Care Receive Vitamin D to Prevent Falls? Results of a Randomized Trial. Journal of the American Geriatrics Society. 53(11). 1881–1888. 224 indexed citations
10.
Stein, Mark S. & John D. Wark. (2003). An update on the therapeutic potential of vitamin D analogues. Expert Opinion on Investigational Drugs. 12(5). 825–840. 29 indexed citations
11.
Flicker, Leon, Robert J. MacInnis, Caryl Nowson, et al.. (2003). Serum Vitamin D and Falls in Older Women in Residential Care in Australia. Journal of the American Geriatrics Society. 51(11). 1533–1538. 173 indexed citations
12.
Stein, Mark S. & John D. Wark. (2003). An update on the therapeutic potential of vitamin D analogues. Expert Opinion on Investigational Drugs. 12(5). 825–840. 1 indexed citations
13.
Scherer, Samuel, et al.. (2002). A multidisciplinary practice guideline for hip fracture prevention in residential aged care. Australasian Journal on Ageing. 21(4). 203–209. 4 indexed citations
14.
Stein, Mark S., Leon Flicker, Samuel Scherer, et al.. (2001). Relationships with serum parathyroid hormone in old institutionalized subjects. Clinical Endocrinology. 54(5). 583–592. 31 indexed citations
15.
Thomas, C. David L., Mark S. Stein, S A Feik, John D. Wark, & John G. Clement. (2000). Determination of age at death using combined morphology and histology of the femur. Journal of Anatomy. 196(3). 463–471. 31 indexed citations
16.
Stein, Mark S., John D. Wark, Samuel Scherer, et al.. (1999). Falls Relate to Vitamin D and Parathyroid Hormone in an Australian Nursing Home and Hostel. Journal of the American Geriatrics Society. 47(10). 1195–1201. 157 indexed citations
17.
Stein, Mark S., C. David L. Thomas, S A Feik, John D. Wark, & John G. Clement. (1998). Bone size and mechanics at the femoral diaphysis across age and sex. Journal of Biomechanics. 31(12). 1101–1110. 59 indexed citations
18.
Stein, Mark S., David Packham, Peter R. Ebeling, John D. Wark, & Gavin J. Becker. (1996). Prevalence and risk factors for osteopenia in dialysis patients. American Journal of Kidney Diseases. 28(4). 515–522. 114 indexed citations
19.
Stein, Mark S., Samuel Scherer, Sarah L. Walton, et al.. (1996). Risk factors for secondary hyperparathyroidism in a nursing home population. Clinical Endocrinology. 44(4). 375–383. 73 indexed citations
20.
Fink, Hermann, et al.. (1962). �ber die verschiedene antinekrogene Wirkung von ?-Tocopherol und ?-Tocopherol und �ber das Vorkommen von Tocopherolen in Erbsen. Die Naturwissenschaften. 49(6). 134–135. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beatriz Oliveri Breakdown of academic impact, for papers by Frazer H. Anderson Breakdown of academic impact, for papers by Mary K. Beard Breakdown of academic impact, for papers by Göran Toss Breakdown of academic impact, for papers by C. L. Donaldson Breakdown of academic impact, for papers by Lisa Ceglia Breakdown of academic impact, for papers by P Bordier Breakdown of academic impact, for papers by Edith Lau Breakdown of academic impact, for papers by Anna Maria Formenti Breakdown of academic impact, for papers by Kerry E Broe
Rankless by CCL
2026